Skip to content

Clinical trials

Invasive Fungal Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Invasive Fungal Infections Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20071
20083
20091
20111
20121
20173
20183
20202
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Inc3
Astellas Pharma Global Development, Inc.2
Basilea Pharmaceutica2
M.D. Anderson Cancer Center2
National Institute of Allergy and Infectious Diseases (NIAID)2
University of Pittsburgh2
Children's Oncology Group1
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
F2G Biotech GmbH1
F2G Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Invasive Fungal Infections24
Mycoses10
Aspergillosis3
Candidiasis3
Hematologic Neoplasms3
Candidemia2
Candidiasis, Invasive2
Coccidioidomycosis2
Fungemia2
Leukemia2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.